MedPath

Clinical Outcome of Lipiflow Treatment Prior to Cataract Surgery in Dry Eye Patients

Not Applicable
Conditions
Dry Eye
Interventions
Device: Lipiflow Thermal pulsation
Registration Number
NCT04457999
Lead Sponsor
Samsung Medical Center
Brief Summary

To investigate the clinical outcome of Lipiflow treatment prior to cataract surgery in patients with meibomian gland dysfunction and dry eye disease

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients older than 21, who will get catarct surgeyr
  • Patients whose visual acuity anticipated better than 20/25 after surgery
  • Patients with informed consent
  • Patients with meibomian gland dysfunction
Exclusion Criteria
  • ocular injury, active injection
  • uncontrolled systemic disease
  • Contact lens wear within 1 month
  • Allergic to fluorescein sodium or topical anesthetics
  • ocular surgery or trauma within 6 months
  • disorder of lid anatomy
  • other reason for decreased vision other than cataract
  • anticipated visual acuity less than 20/25
  • Patients less than 20 years.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Lipiflow treatmentLipiflow Thermal pulsationLipiflow thermal pulsation prior to cataract surgery
Primary Outcome Measures
NameTimeMethod
improvement of dry eye symptom1 month

ocular dryness

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath